Related Experiment Videos
Outcomes after stereotactically guided pallidotomy for advanced Parkinson's disease
D Kondziolka1, E Bonaroti, S Baser
1Department of Neurological Surgery, University of Pittsburgh, Pennsylvania, USA. kondziol@neuronet.pitt.edu
Journal of Neurosurgery
|February 9, 1999
Summary
Stereotactically guided posteroventral pallidotomy offers significant benefits for advanced Parkinson's disease (PD) patients refractory to medication. This surgical intervention demonstrated minimal morbidity and notable improvements in motor function and quality of life.
Area of Science:
- Neurosurgery
- Neurology
- Movement Disorders
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- Medication often becomes ineffective in advanced stages of PD.
- Stereotactically guided posteroventral pallidotomy is an emerging surgical option for advanced PD.
Purpose of the Study:
- To assess the safety and efficacy of posteroventral pallidotomy in advanced PD.
- To document operative morbidity and functional outcomes using validated scales and patient surveys.
Main Methods:
- Prospective analysis of 58 advanced PD patients (age 40-79) undergoing surgery (1994-1997).
- Evaluation using the Unified Parkinson's Disease Rating Scale (UPDRS) during medication 'on' and 'off' states.
- Patient surveys to assess functional gains and symptom improvement.
Main Results:
- Temporary morbidity in 6.9% of patients (dysarthria, confusion); 1.7% had persistent dysarthria.
- No visual field deficits or hemorrhages occurred; all patients discharged within 24 hours.
- Significant postsurgical improvements in UPDRS off-period scores, tremor, rigidity, bradykinesia, and dyskinesia (p < 0.005), persisting beyond 1 year for some symptoms.
Conclusions:
- MRI-guided pallidotomy with macrostimulation is associated with minimal morbidity in advanced PD.
- The procedure significantly reduces dyskinesia and off-period disability in medically refractory patients.
- Symptomatic and functional improvements are valuable to patients and persist beyond the first year.